STEPHANIE LEDL: Open Payments
NPI 1730329640 · SPRINGFIELD, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$558 in 20 payments from 15 companies in 2025. Trend: 2023 $115 · 2024 $110 · 2025 $558
Food & beverage: $390Education: $168
| Company | Payments | Amount |
|---|---|---|
| Incyte Corporation | 1 | $100 |
| PFIZER INC. | 4 | $86 |
| AstraZeneca Pharmaceuticals LP | 1 | $68 |
| Merck Sharp & Dohme LLC | 2 | $44 |
| GENZYME CORPORATION | 2 | $43 |
| Astellas Pharma US Inc | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| GlaxoSmithKline, LLC. | 1 | $25 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
Products named: IMFINZI, SARCLISA, ELREXFIO, Vyloy, KISQALI, OJJAARA, XYNTHA, WELIREG.
Industry payments across MO — which companies pay providers there.
